Comparative Effectiveness and Safety of Intrauterine Contraception and Tubal Ligation.
Eleanor Bimla Schwarz, Carrie A Lewis, Melanie S Dove...
https://pubmed.ncbi.nlm.nih.gov/35194746Actively Recruiting
Led by University of California, San Francisco · Updated on 2026-01-26
650
Participants Needed
1
Research Sites
N/A
Total Duration
U
University of California, San Francisco
Lead Sponsor
E
Essential Access Health
Collaborating Sponsor
Researchers are evaluating whether providing women who strongly want to avoid future pregnancy with detailed information comparing tubal sterilization to long-acting reversible contraceptives (LARC) improves their perceived access to different contraceptive options. The study aims to support patient-centered contraceptive care by increasing knowledge and access to all long-acting contraceptives. This research also seeks to reduce the number of women who regret permanent sterilization and address racial disparities in surgical sterilization. Participants are randomly assigned to one of two groups: one group accesses a new website that compares tubal sterilization and LARC based on recent patient-centered outcomes research, while the other group views an existing Planned Parenthood webpage focused on tubal sterilization. These web-based resources serve as educational interventions to help patients prepare for discussions with their healthcare providers about contraception. During the study, participants complete a baseline survey, explore their assigned website, and then complete a brief follow-up survey immediately afterward. They also complete another follow-up survey three months later. Researchers measure outcomes such as perceived access to long-acting contraceptives, contraceptive counseling quality, patient-provider interactions, knowledge about contraceptive methods, use of preferred contraception, and willingness to recommend the website. The study includes safety and adherence monitoring through surveys and lasts at least three months from enrollment.
CONDITIONS
Patient-centered Information on Permanent Contraception
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) for eligibility assessment
Duration - Single session
Participants are introduced to one of two educational websites to provide information on tubal sterilization and long-acting reversible contraceptives to support contraceptive decision-making.
1 visit (online introduction to website)
Duration - 3 months
Participants complete follow-up assessments to evaluate perceived access, knowledge, counseling experience, contraceptive use, and satisfaction with the educational websites.
1 follow-up visit (online or remote) at 3 months
Total: 1 location
1
University of California, San Francisco
San Francisco, California, United States, 94143
Actively Recruiting
E
Eleanor Schwarz, MD, MS
A
Agatha Okobi
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Eleanor Bimla Schwarz, Carrie A Lewis, Melanie S Dove...
https://pubmed.ncbi.nlm.nih.gov/35194746